|drug1878||Nitric Oxide delivered via LungFit™ system Wiki||1.00|
|D053120||Respiratory Aspiration NIH||0.32|
|D012120||Respiration Disorders NIH||0.26|
|D012140||Respiratory Tract Diseases NIH||0.21|
|D011024||Pneumonia, Viral NIH||0.12|
|D045169||Severe Acute Respiratory Syndrome NIH||0.05|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This study is being conducted to evaluate the efficacy of acupressure in promoting health and well-being among healthcare workers during the COVID-19 pandemic. The investigators hypothesize that providing participants with a remote and standardized self-acupressure training program will improve HRQOL and the perception of stress. In the event that the study demonstrates acupressure to be safe and effective for this indication, the training could be scaled up and deployed at low-cost nationally and internationally.
Description: SF-12v2Measure: Quality of Life Time: 8 weeks
Description: Perceived Stress ScaleMeasure: Perception of stress Time: 8 weeks